For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Zinc Gluconate Group | interventions: Zinc gluconate (200g/capsule) one capsule once in the morning after breakfast for 60 days. Adapalene 0.3% + benzoyl peroxide 2.5% gel to be applied once at night for 60 days. Zinc gluconate: oral zinc gluconate 200mg Adapalene 0.003 MG/MG / Benzoyl Peroxide 0.025 MG/MG Topical Gel \[Epiduo\]: Adapalene 0.3% + Benzoyl peroxide 2.5% gel applied once daily in the evening | 0 | None | 0 | 11 | 1 | 11 | View |
| Placebo Group | interventions: Placebo capsule, one capsule once in the morning after breakfast for 60 days. Adapalene 0.3% + benzoyl peroxide 2.5% gel to be applied once at night for 60 days. Adapalene 0.003 MG/MG / Benzoyl Peroxide 0.025 MG/MG Topical Gel \[Epiduo\]: Adapalene 0.3% + Benzoyl peroxide 2.5% gel applied once daily in the evening Placebo: contains cornstarch | 0 | None | 0 | 12 | 0 | 12 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| vomiting | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |